東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Molecular oncology = underlying mech...

Farooqi, Ammad Ahmad.

FindBook

Google Book

Amazon

博客來

Molecular oncology = underlying mechanisms and translational advancements /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Molecular oncology/ edited by Ammad Ahmad Farooqi, Muhammad Ismail.
其他題名:	underlying mechanisms and translational advancements /
其他作者:	Farooqi, Ammad Ahmad.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	x, 302 p. :ill., digital ;24 cm.
內容註:	- Microtubule targeting agents in cancer therapy: Elucidating the underlying molecular mechanisms -- Adenosine signaling pathways as potential therapeutic targets in cancer disease -- Anticancer activities of Hippophae rhamnoides: Journey from Benchtop to the Bedside -- Emerging role of ncRNAs in cancer biology: techniques for diagnostic monitoring and potential ncRNA-based therapies -- Clinical and translational research on the pathophysiology of several ocular tumors types -- Exosomes and cancer: from diagnosis to therapy -- Blood-based Cancer Detection: Towards Solving Diagnostic Puzzle -- Non-coding RNAs, Critical Therapy Targets against Cancer - Detection of Virus-caused Cancer in Publicly Available Next Generation Sequencing Data -- TRAIL mediated signaling in prostate cancer -- Index.
Contained By:	Springer eBooks
標題:	Cancer - Molecular aspects. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-53082-6
ISBN:	9783319530826

Molecular oncology = underlying mechanisms and translational advancements /
Molecular oncologyunderlying mechanisms and translational advancements /[electronic resource] :edited by Ammad Ahmad Farooqi, Muhammad Ismail. - Cham :Springer International Publishing :2017. - x, 302 p. :ill., digital ;24 cm.

- Microtubule targeting agents in cancer therapy: Elucidating the underlying molecular mechanisms -- Adenosine signaling pathways as potential therapeutic targets in cancer disease -- Anticancer activities of Hippophae rhamnoides: Journey from Benchtop to the Bedside -- Emerging role of ncRNAs in cancer biology: techniques for diagnostic monitoring and potential ncRNA-based therapies -- Clinical and translational research on the pathophysiology of several ocular tumors types -- Exosomes and cancer: from diagnosis to therapy -- Blood-based Cancer Detection: Towards Solving Diagnostic Puzzle -- Non-coding RNAs, Critical Therapy Targets against Cancer - Detection of Virus-caused Cancer in Publicly Available Next Generation Sequencing Data -- TRAIL mediated signaling in prostate cancer -- Index.

Cancer is a multifaceted and genomically complex disease and data obtained through high throughput technologies has provided near complete resolution of the landscape of how genomic, genetic and epigenetic mutations in cancerous cells effectively influence homeostasis of signaling networks within these cells, between cancerous cells, tumor microenvironment and at the organ level. Increasingly sophisticated information has helped us in developing a better understanding of the underlying mechanisms of cancer, and it is now known that intra-tumor genetic heterogeneity, cellular plasticity, dysregulation of spatio-temporally controlled signaling cascades, and loss of apoptosis are contributory in cancer development, progression and the development of resistance against different therapeutics. It is becoming progressively more understandable that earlier detection of pre-existing or emerging resistance against different therapeutics may prove to be helpful in personalizing the use of targeted cancer therapy. Despite the fact that there is a continuously increasing list of books, being guest edited by researchers, books on the subject are often composed of invited reviews without proper sequence and continuity and designed for a particular readership. This book progressively shifts and guides the readers from basic underlying mechanisms to translational approaches to treat cancer.

ISBN: 9783319530826

Standard No.: 10.1007/978-3-319-53082-6doiSubjects--Topical Terms:

661419
Cancer
--Molecular aspects.

LC Class. No.: RC268.4

Dewey Class. No.: 616.994

Molecular oncology = underlying mechanisms and translational advancements /
LDR:03185nmm a2200313 a 4500 001 2092487
003 DE-He213
005 20170330161549.0
006 m d
007 cr nn 008maaau
008 171117s2017 gw s 0 eng d
020 $a 9783319530826 $q (electronic bk.)
020 $a 9783319530819 $q (paper)
024 7 $a 10.1007/978-3-319-53082-6 $2 doi
035 $a 978-3-319-53082-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC268.4
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.994 $2 23
090 $a RC268.4 $b .M718 2017
245 0 0 $a Molecular oncology $h [electronic resource] : $b underlying mechanisms and translational advancements / $c edited by Ammad Ahmad Farooqi, Muhammad Ismail.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a x, 302 p. : $b ill., digital ; $c 24 cm.
505 0 $a - Microtubule targeting agents in cancer therapy: Elucidating the underlying molecular mechanisms -- Adenosine signaling pathways as potential therapeutic targets in cancer disease -- Anticancer activities of Hippophae rhamnoides: Journey from Benchtop to the Bedside -- Emerging role of ncRNAs in cancer biology: techniques for diagnostic monitoring and potential ncRNA-based therapies -- Clinical and translational research on the pathophysiology of several ocular tumors types -- Exosomes and cancer: from diagnosis to therapy -- Blood-based Cancer Detection: Towards Solving Diagnostic Puzzle -- Non-coding RNAs, Critical Therapy Targets against Cancer - Detection of Virus-caused Cancer in Publicly Available Next Generation Sequencing Data -- TRAIL mediated signaling in prostate cancer -- Index.
520 $a Cancer is a multifaceted and genomically complex disease and data obtained through high throughput technologies has provided near complete resolution of the landscape of how genomic, genetic and epigenetic mutations in cancerous cells effectively influence homeostasis of signaling networks within these cells, between cancerous cells, tumor microenvironment and at the organ level. Increasingly sophisticated information has helped us in developing a better understanding of the underlying mechanisms of cancer, and it is now known that intra-tumor genetic heterogeneity, cellular plasticity, dysregulation of spatio-temporally controlled signaling cascades, and loss of apoptosis are contributory in cancer development, progression and the development of resistance against different therapeutics. It is becoming progressively more understandable that earlier detection of pre-existing or emerging resistance against different therapeutics may prove to be helpful in personalizing the use of targeted cancer therapy. Despite the fact that there is a continuously increasing list of books, being guest edited by researchers, books on the subject are often composed of invited reviews without proper sequence and continuity and designed for a particular readership. This book progressively shifts and guides the readers from basic underlying mechanisms to translational approaches to treat cancer.
650 0 $a Cancer $x Molecular aspects. $3 661419
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Cancer Research. $3 891172
650 2 4 $a Oncology. $3 751006
700 1 $a Farooqi, Ammad Ahmad. $3 3226406
700 1 $a Ismail, Muhammad. $3 3226407
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-53082-6
950 $a Biomedical and Life Sciences (Springer-11642)